Wednesday, June 17, 2009 4:150PM EST:
Hologic Presents at the Jefferies 3rd Annual Healthcare Conference
Read Press Release
Listen To Conference Call Webcast Audio
View Presentation

Tax Consequences of Merger for Cytyc Stockholders:
Click  here for the tax consequences of the merger for Cytyc stockholders

Welcome

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, gynecological surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including reagents for a variety of DNA and RNA analysis applications.

Headquartered in Bedford, Massachusetts, Hologic employs more than 4,000 employees worldwide. The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol "HOLX" and included in the Nasdaq-100 Index.